Co-Diagnostics, Inc.
CODX
$1.55
$0.021.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.75M | -5.89M | -7.73M | -7.53M | -11.03M |
| Total Depreciation and Amortization | 267.60K | 267.40K | 291.40K | 280.40K | 357.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.19M | 497.60K | 309.60K | -174.60K | 713.90K |
| Change in Net Operating Assets | 92.10K | -782.70K | -1.16M | -1.32M | 1.73M |
| Cash from Operations | -6.20M | -5.90M | -8.29M | -8.75M | -8.23M |
| Capital Expenditure | -132.00K | -75.10K | -401.10K | -91.90K | -73.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -197.50K | 2.25M | 17.47M | 7.45M | 339.00K |
| Cash from Investing | -329.40K | 2.17M | 17.07M | 7.36M | 266.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.97M | 4.06M | 429.00K | 354.70K | 103.90K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.97M | 4.06M | 429.00K | 354.70K | 103.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 440.70K | 328.80K | 9.21M | -1.03M | -7.86M |